Quick Answer
Ultragenyx Pharmaceutical Inc. reported Shares Outstanding of 96.60 million shares for fiscal year 2025.
Ultragenyx Pharmaceutical Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 96.60M | +4.4% |
| 2024 | 92.50M | +12.4% |
| 2023 | 82.32M | +17.3% |
| 2022 | 70.20M | +1.2% |
| 2021 | 69.34M | +3.8% |
| 2020 | 66.82M | +15.5% |
| 2019 | 57.84M | +13.7% |
| 2018 | 50.86M | +15.2% |
| 2017 | 44.17M | +7.1% |
| 2016 | 41.24M | +6.1% |
| 2015 | 38.88M | +21.8% |
| 2014 | 31.93M | +747.9% |
| 2013 | 3.77M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 96.44M | +4.5% | +0.1% |
| June 30, 2025 | 96.35M | +4.6% | +2.6% |
| March 31, 2025 | 93.90M | +13.0% | +1.5% |
| December 31, 2024 | 92.48M | +12.4% | +0.2% |
| September 30, 2024 | 92.30M | +27.9% | +0.2% |
| June 30, 2024 | 92.14M | +28.9% | +10.9% |
| March 31, 2024 | 83.09M | +17.6% | +0.9% |
| December 31, 2023 | 82.32M | +17.3% | +14.1% |
- Ultragenyx Pharmaceutical Inc. showed an increase of +4.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Ultragenyx Pharmaceutical Inc.’s shares outstanding has grown by 2464.9% (from 3.77 million shares to 96.60 million shares).
- The most recent figure is from Ultragenyx Pharmaceutical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: